Search - tctmd.com

Displaying 321 - 340 of 432

Sort: Relevancy | Date

Presentation

Device Closure of PFO After Stroke: Pooled Analysis of Completed Randomized Trials

Presenter: David M. Kent

February 22, 2016

Presentation Scripps 2016

Can we identifiy the patient who will benefit from PFO closure?

Presenter: John D. Carroll

February 04, 2016

Presentation

PFO Closure for Cryptogenic Stroke: To Close or Not To Close That Is Still The Question

Presenter: Pablo Rengifo

October 29, 2015

Presentation TCT 2015

RESPECT: A Prospective Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke Long-term Results

Presenter: John D. Carroll, Ioanna Kosmidou

October 15, 2015

Presentation TCT 2015

RESPECT: A Prospective Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke – Long-term Results

Presenter: John D. Carroll

October 15, 2015

Presentation TCT 2015

Paravalvular Leak Closure: New Devices and the State of the Art

Presenter: Ziyad M. Hijazi, Robert J. Sommer

October 14, 2015

Presentation TCT 2015

The State of the Art of Transcatheter Treatment of Aortic Coarctation in Adults

Presenter: Ziyad M. Hijazi, Robert J. Sommer, John P. Cheatham

October 14, 2015

Presentation TCT 2015

ADO II and Other Approaches to PDA Closure

Presenter: Ziyad M. Hijazi, Robert J. Sommer, Lars Sondergaard

October 14, 2015

Presentation TCT 2015

Melody, Edwards, and Venus Valves: Lessons Learned and Future Directions

Presenter: Ziyad M. Hijazi, Robert J. Sommer, Thomas K. Jones

October 14, 2015

Presentation TCT 2015

The FDA-Mandated Postapproval Study of the Amplazter ASO Device

Presenter: David W.M. Muller, John F. Rhodes, Zahid Amin

October 14, 2015

Presentation TCT 2015

Acroredis, Iris Fit, and CARAG ASD Occluder

Presenter: David W.M. Muller, John F. Rhodes, Horst Sievert

October 14, 2015

Presentation TCT 2015

GSO: Good-bye Helex

Presenter: David W.M. Muller, John F. Rhodes

October 14, 2015

Presentation TCT 2015

PFO and Hypoxemia: Patient Selection

Presenter: David Hildick-Smith, Jonathan M. Tobis, John C. Messenger

October 14, 2015

Presentation TCT 2015

Paradoxical Embolic Myocardial Infarction: Analysis of More Than 6500 Patients With AMI

Presenter: David Hildick-Smith, Jonathan M. Tobis, Franz X. Kleber

October 14, 2015

Presentation TCT 2015

Are There Certain Patients for Whom PFO Closure for Migraine Should Now Be Considered Acceptable?

Presenter: David Hildick-Smith, Jonathan M. Tobis, Robert J. Sommer

October 14, 2015

Presentation TCT 2015

PRIMA Trial: Lessons Learned

Presenter: David Hildick-Smith, Jonathan M. Tobis

October 14, 2015

Presentation TCT 2015

PREMIUM Trial: Lessons Learned

Presenter: David Hildick-Smith, Jonathan M. Tobis

October 14, 2015

Presentation TCT 2015

Update on the ROPE Study: Emerging Insights

Presenter: John D. Carroll, Mark Reisman, David E. Thaler

October 14, 2015

Presentation TCT 2015

Risk of Paradoxical Embolism With Pacemaker Leads

Presenter: John D. Carroll, Mark Reisman, Samir R. Kapadia

October 14, 2015

Presentation TCT 2015

Clinical Practice in 2015: When Closure Is and Is Not Justified

Presenter: John D. Carroll, Mark Reisman

October 14, 2015

Advertisement

Device Closure of PFO After Stroke: Pooled Analysis of Completed Randomized Trials

Can we identifiy the patient who will benefit from PFO closure?

PFO Closure for Cryptogenic Stroke: To Close or Not To Close That Is Still The Question

RESPECT: A Prospective Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke Long-term Results

RESPECT: A Prospective Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke – Long-term Results

Paravalvular Leak Closure: New Devices and the State of the Art

The State of the Art of Transcatheter Treatment of Aortic Coarctation in Adults

ADO II and Other Approaches to PDA Closure

Melody, Edwards, and Venus Valves: Lessons Learned and Future Directions

The FDA-Mandated Postapproval Study of the Amplazter ASO Device

Acroredis, Iris Fit, and CARAG ASD Occluder

GSO: Good-bye Helex

PFO and Hypoxemia: Patient Selection

Paradoxical Embolic Myocardial Infarction: Analysis of More Than 6500 Patients With AMI

Are There Certain Patients for Whom PFO Closure for Migraine Should Now Be Considered Acceptable?

PRIMA Trial: Lessons Learned

PREMIUM Trial: Lessons Learned

Update on the ROPE Study: Emerging Insights

Risk of Paradoxical Embolism With Pacemaker Leads

Clinical Practice in 2015: When Closure Is and Is Not Justified

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content